Tumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C) Antibody (APC)

Este producto es parte de TNFRSF10C - TNF receptor superfamily member 10C
Product Graph
689€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Tumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C) Antibody (APC)
category
Primary Antibodies
provider
Abbexa
reference
abx270630
tested applications
FCM

Description

Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) Antibody (APC) is a Rabbit Polyclonal Antibody conjugated to APC against Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) for use in flow cytometry.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Tumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C)
Host
Rabbit
Reactivity
Human
Recommended Dilution
FCM: 1-5 µl/106 cells. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
APC
Isotype
IgG
Purification
Purified by antigen-specific affinity chromatography.
Size 1
100 tests
Size 2
200 tests
Size 3
500 tests
Form
Liquid
Tested Applications
FCM
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Please enquire.
Storage
Aliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light.
Dry Ice
No
Alias
Tumor necrosis factor receptor superfamily member 10C,LIT,DCR1,TRID,CD263,TRAILR3,TRAIL-R3,DCR1-TNFR,Antagonist decoy receptor for TRAIL/Apo-2L,Decoy TRAIL receptor without death domain,TNF-related apoptosis-inducing ligand receptor 3
Background
Antibody anti-TNFRSF10C
Status
RUO

Descripción

TNFRSF10C (TNF receptor superfamily member 10C), also known as TRAIL-R3 or Decoy Receptor 1 (DcR1), is part of the TNF receptor superfamily and specifically the death receptor subset involved in binding the ligand TRAIL (TNF-related apoptosis-inducing ligand). Unlike other TRAIL receptors, such as TNFRSF10A (TRAIL-R1) and TNFRSF10B (TRAIL-R2), which can initiate apoptosis upon TRAIL binding, TNFRSF10C is categorized as a “decoy” receptor. This classification is due to its structural attributes that prevent it from transmitting apoptotic signals. Instead, TNFRSF10C functions by binding TRAIL and preventing it from interacting with apoptosis-inducing receptors, thereby modulating apoptosis sensitivity in cells. TNFRSF10C is predominantly expressed in normal, non-transformed tissues, suggesting a role in protecting healthy cells from TRAIL-induced apoptosis. It has gained scientific interest due to its potential implications in cancer biology, where it may contribute to tumor resistance against TRAIL-based therapies.

Related Products

Pr22276

Recombinant Human TRAIL R3

Ver Producto
Pr22277

Recombinant Human TRAIL R3

Ver Producto
abx001051

Tumor Necrosis Factor Receptor Superfamily Member 10C (TNFRSF10C) Antibody

TNFRSF10C Antibody is a Rabbit Polyclonal antibody against TNFRSF10C. The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contains an extracellular TRAIL-binding domain and a transmembrane domain, but no cytoplasmic death domain. This receptor is not capable of inducing apoptosis, and is thought to function as an antagonistic receptor that protects cells from TRAIL-induced apoptosis. This gene was found to be a p53-regulated DNA damage-inducible gene. The expression of this gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.

Ver Producto